Abstract. In 2008, the World Health Organization (WHO) introduced a new hematological neoplasm category; myelodysplastic/myeloproliferative neoplasms (MDS/MPN), which included four main subcategories. This disease is often misdiagnosed, which delays effective therapy. The present study evaluated the role of routine blood examinations and morphological analysis of peripheral blood cells in the reliable diagnosis of MDS/MPN. In total, 236 adult MDS/MPN patients were analyzed. The analysis included 10 routine blood parameters measured using a Sysmex XE-2100™, 3 differential percentage parameters and 7 morphological features of peripheral blood cells which were analyzed by optical microscopy, and 3 differential absolute count numbers obtained based on the corresponding differential percentages and absolute count of blood cells. The parameters were compared among the subcategories and a value of P<0.05 was considered to indicate a statistically significant difference. The median white blood cell and hemoglobin counts of the patients were 18.0x10 9 /l and 88 g/l, respectively. The proportion of monocytes increased to 8% (1.82x10 9 /l), the proportion of blast cells increased to 1% (0.5x10 9 /l) and that of neutrophil precursors increased to 10% (1.98x10 9 /l). A total of 87% of all patients presented with hypogranulation and 71% presented with abnormal condensed nuclear chromatin in granulocytes. Atypical monocytes were observed in 73% of all patients and Pseudo-Pelger cells were observed in 60%. Significant differences were detected among the subcategories. The present study demonstrated that combining blood routine parameters and the morphological analysis of peripheral blood cells have an essential role in the reliable diagnosis of MDS/MPN based on WHO categories.
Introduction
In 2001, the hematopoietic and lymphoid tissue tumor classification was revised (1) to include the definition of a type of myeloid tumor known as myelodysplastic/myeloproliferative neoplasm (MDS/MPN). This type of tumor is a rare clonal myeloid neoplasm that initially presents with overlapping myelodysplastic and myeloproliferative features (1), with the incidence estimated at 0.1-3/100,000 individuals (2) .
In 2008, the World Health Organization (WHO) further classified MDS/MPN into four subcategories: Juvenile myelomonocytic leukemia (JMML), atypical chronic myeloid leukemia (BCR-ABL1_negative; aCML), chronic myelomonocytic leukemia (CMML), and unclassifiable MDS/MPN (MDS/MPN-U) (3) . It has been demonstrated that MDS/MPN is a heterogeneous entity at various molecular and clinical levels and has no specific molecular markers. Patients with MDS/MPN have a relatively long survival time and there is no treatment consensus except for the administration of allogenic hematopoietic stem cell transplantation (allo-HSCT, which requires a match of ≥3 loci with the HLA gene) (4) . The current study focused on the last three types of tumors, which include hematologic malignancies that significantly harm adult patients.
Although certain genetic mutations, including RAS, TET2, SRF2, ASXL1, SETBP1, CSF3R, SF3B1, have been detected in patients, MDS/MPN remains a challenging disease to diagnose due to its heterogeneity in clinical and laboratory features (3) . Examinations of peripheral blood and bone marrow morphology are important in the diagnosis of MDS/MPN (2) . The aim of the current study was to assess the importance of routine blood parameters in the reliable diagnosis of MDS/MPN, by measuring white blood cell (WBC) differential counts and the morphological features of peripheral blood cells. 9 /l and significantly differed by subtype; the highest average blood counts were observed in the aCML group, followed by CMML, and then the MDS/MPN-U group (P=0.02). The median hemoglobin (Hb) value was 88 g/l and did not differ between different subtypes (P>0.05). By contrast, the median platelet (PLT) count was 116x10 9 /l and differed significantly by subtype; specifically, the PLT count was significantly higher in the MDS/MPN-U group than in the other two groups (P=0.04). Median mean corpuscular volume (MCV) level was 88 fl, however, there were Table I . Age and male to female ratio in cases of MDS/MPN. no significant differences in MCV levels among the subtypes (P>0.05). This was also the case with median platelet distribution width (PDW) levels. The eosinophil and basophil count and the red blood cell distribution width (RDW) were in the normal range and did not significantly differ among subtypes (P>0.05).
Routine blood examinations combined with morphological analysis for the diagnosis of myelodysplastic/myeloproliferative neoplasms

Results
Age and male to female (M:F) ratio of MDS/MPN patients.
The average positive rate and NAP score of all patients were 40% and 74 points, respectively, and were within the normal range. The NAP score of the MDS/MPN-U group was 160 points, which was significantly higher than those observed in other groups (P=0.02). Table II . Routine blood parameters and the NAP scores of MDS/MPNs cases. Differential count of the peripheral blood cells. Table III presents the peripheral blood cell differential count. The absolute count and percentage of monocytes in the peripheral blood of MDS/MPN patients increased significantly and differed by subtype (P=0.02, P=0.02, respectively; CMML group>aCML group>MDS/MPN-U group). The percentage and absolute counts of blasts in the peripheral blood were also increased, however there were no significant differences among the subtypes. The proportion of neutrophil precursors in the peripheral blood increased to 10%, (1.98x10 9 /l) and significantly differed by subtype (aCML group>CMML group>MDS/MPN-U group; P=0.02). Table IV presents the morphological features of MDS/MPN patients. The morphological features of peripheral blood cells were analyzed in detail and it was observed that 47% of the patients presented with blasts and 83% presented with neutrophile precursors. A total of 73% of all patients presented with atypical monocytes and these abnormal cells were most frequently observed in the CMML group (P=0.02). Moreover, Pseudo-Pelger cells were observed in 60% of patients, most frequently in the MDS/MPN-U group (P=0.04). Furthermore, 71% of all patients presented with abnormal condensed nuclear chromatin and hypogranulation in granulocytes, and 68% presented with nucleus-cytoplasm synchrony in granulocytes, particularly in neutrophil precusors.
Morphological features of peripheral blood cells in MDS/MPN patients.
Discussion
MDS/MPN is a newly defined independent hematological malignancy. Currently, its diagnosis primarily depends on analyses performed in the clinic and laboratory. Certain genetic characteristics of MDS/MPN have been documented (3,4) , however, the diagnosis of this disease lacks specific markers. The present study demonstrated that routine blood examinations, combined with WBC differential counts and morphological analyses of peripheral blood cells, are important in the diagnosis of MDS/MPN.
An innate characteristic of MDS/MPN is that it exhibits overlapping dysplastic and proliferative features simultaneously (3). In the present study, the median age, M:F ratio, WBC count and platelet count of all patients were 70 years, 3.0:1, 19.8x10 9 /l and 116x10 9 /l (range, 9-1432x10 9 /l), respectively. These data differ slightly from that of a previous study, which were 58 years, 1.65:1, 18.0x10 9 /l and 158x10 9 /l, respectively (6) . This difference may be due to a larger number of patients included in the current study and the fact that patients with JMML were excluded. Within the subtypes of MDS/MPN, the WBC count of CMML group (25.7x10 9 /l; range, 11-23x10 9 /l) is slightly higher than counts reported in previous studies. The median age of CMML group was 80 years (range, 18-84 years), higher than the median ages of 57-72 years reported in previous studies (6) . In the present study, the platelet count was 88x10 9 /l, lower than in previous reports where it varied from 197-220x10 9 /l (7-10). In the aCML group, the median age, M:F ratio, WBC count and platelet count were 70 years, 2.7:1, 31.4x10 9 /l and 115x10 9 /l, respectively, in the current study, whereas in previous studies, these parameters all tended to be lower; 68-72 years, 0.85:1 to no gender tendency, 24-40.8x10 9 /l and 112x10 9 /l, respectively (11) (12) (13) (14) (15) (16) . In the MDS/MPN-U group, these parameters were 72 years, 7.0:1, 10.2x10 9 /l and 249x10 9 /l (ranging from 22-1432x10 9 /l) in the present study, whereas in previous studies, they were 68-70 years, 1.0:1-2.5:1, 7.5-17x10 9 /l, 100-653x10 9 /l, respectively (6, 15, (17) (18) (19) . All the results suggest that MDS/MPN is a type of disease that generally occurs in the elderly, with a high male incidence rate (although the M:F ratio of aCML remains uncertain), elevated counts of WBC and varying platelet counts. The WBC count in the aCML group is higher than in the other subtypes and the platelet counts greatly vary (range from 22-1432x10 9 /l). In the present study, the differential counts of peripheral blood cells in MDS/MPN patients obtained demonstrated that 47% of MDS/MPN patients presented with myeloblasts and 83% presented with neutrophil precursors. The median Table III . Differential counts of peripheral blood cells in MDS/MPNs cases. Table IV . Presence of morphology features of peripheral blood cells in percentages of the MDS/MPNs cases. proportion of monocytes was elevated to 8% (1.82x10 9 /l), the median level of blasts was 1% (0.19x10 9 /l) and the proportion of neutrophil precursors was 10% (1.98x10 9 /l). In the CMML group, the median proportion of monocytes was 24% (4.2x10 9 /l), which was the highest among the three subtypes and the median proportion of blasts and neutrophil precursors were 0.6% and 3%, respectively. This is similar to proportions observed within this group in previous studies (7) (8) (9) (10) . Therefore, all results indicate the percentage of monocytes in CMML patients is >10%, the percentage of blasts is <5% and neutrophil precursors make up <10% in peripheral blood.
All patients CMML aCML MDS/MPN-U ------------------------------------------------------------------------------------------------------------
All patients
In the current study, the median proportion of monocytes, blasts and neutrophil precursors were 6.5% (2.0x10 9 /l), 3.5% and 14% in the aCML group, compared with 2.46-10%, 3.3% and 6.27-10.5%, respectively, in previous studies (3, (11) (12) (13) (14) (15) . The results indicate the percentage of monocytes in the peripheral blood of aCML patients is <10% (but may exceed 1.0x10 9 /l), the percentage of blasts is <5% and the proportion of neutrophil precursors is 5-15%. In the MDS/MPN-U group, these parameters were 5.5% (0.8x10 9 /l), 0.2% (0.05x10 9 /l) and 1.9% (0.43x10 9 /l) in the present study, and were 6% (0.45x10 9 /l), 1% and 4.5% in previous studies, respectively (6) .
The results from differential counts demonstrate that the MDS/MPN patients exhibit a high proportion of monocytes, a low percentage of blast cells and nearly 10% neutrophil precursors. The presence of blasts and neutrophil precursors are frequent features in peripheral blood smears of patients with MDS/MPN and their percentages, together with the proportion of monocytes, are important for the diagnosis of MDS/MPN subtypes.
According to the current study, not only are the number of WBC and proportion of monocytes and nuetrophil precursors increased in MDS/MPN patients, their morphological features are altered. Atypical monocytes were frequently observed, particularly in CMML patients.
Atypical monocytes differ from promonocytes and monoblasts. They contain no nucleolus, exhibit swelling, abnormally folded nuclei, aggregated chromatin, nucleus-cytoplasm asynchrony, variably basophilic plasma, hypo/hypergranulation and tumor-like changes (20, 21) (Fig. 1A and B) . Promonocytes exhibit clear nucleoli, mildly folding nuclei, immature chromatin (particle mesh without obvious aggregation) and a basophilic cytoplasm (Fig. 1C) . By contrast, mature monocytes exhibit an inconspicuous or absent nucleolus, obviously folding nuclei and aggregated chromatin with a grey-blue cytoplasm. When considering the morphology of nuclei on a continuum, with those of mature monocytes at one end and those of immature monocytes at the other end, the morphological features of atypical monocyte nuclei are at the midway point.
A total of 91% of CMML patients, 66% of aCML patients and 30% of MDS/MPN-U patients presented with atypical monocytes. The features of atypical monocytes are important for the characterization of MDS/MPN and its subtypes. Furthermore, accurate identification of atypical monocytes and promonocytes is very important when distinguishing cases of CMML from those of acute myeloid leukemia (AML) (22) . Promonocytes are considered as 'blast equivalents', whereas atypical monocytes are considered as more mature monocytes with dysplastic features. A diagnosis of AML should be made when blasts (including myeloblasts, monoblasts and promonocytes) ≥20% in the peripheral blood or bone marrow, whereas blasts in MDS/MPN should be <20%.
In the present study, it was observed that 87% of the MDS/MPN patients presented with hypogranulation and 71% with abnormal condensed nuclear chromatin. The present study demonstrated that abnormally condensed chromatin is usually presented as the uniform aggregation of accumulation of the nuclear chromatin and is frequently noted as the patchwork of the deeper and lighter staining region. This phenomenon was most frequently identified in the aCML group. Hypogranulation and abnormal condensed nuclear chromatin were the top two most frequently observed morphological changes in the granulocytes of all patients with MDS/MPN. As far as neutrophil precursors were concerned, in peripheral blood, nucleus-cytoplasm asynchrony was observed in 68% of cases. This usually presents as immature tiny chromatin, sometimes with a nucleolus but more mature cytoplasm. Nucleus-cytoplasm asynchrony is generally observed in the maturation model of the nucleus and cytoplasm of the myelocytes and metamylocytes and may be presented in the band granulocytes in MDS/MPN. Pseudo-Pelger cells are also frequently observed on blood slides (Fig. 1D) . The present study demonstrated that, apart from hypogranulation, nucleus-cytoplasm asynchrony is the second most frequent detection in the aCML group and Pseudo-Pelger cells are the second most frequent feature observed in the MDS/MPN-U group. These morphological changes are rarely observed in chronic infectious diseases (23) .
Atypical monocytes, hypogranulation and abnormal condensed nuclear chromatin of granulocytes, nucleus-cytoplasm asynchrony of nuetrophil precursors and Pseudo-Pelger cells are important morphological features in MDS/MPN peripheral blood when diagnosing MDS/MPN and distinguishing MDS/MPN from similar diseases (including AML and various infectious diseases). These morphological features may also help practitioners classify patients into the WHO subtypes of MDS/MPN.
Although bone marrow aspirates, chromosome karyotype analyses, immunophenotype analyses and molecular biological measurements are necessary for a conclusive diagnosis and essential in prognosis assessments of MDS/MPN (6, (24) (25) (26) , routine examinations of whole blood, combining peripheral blood parameters, differential counts and morphological features of peripheral blood cells are the first step and pivotal in the diagnosis and differential diagnosis of MDS/MPN and its WHO subcategories. Early and reliable diagnoses of MDS/MPN and its subtypes are currently only made in this manner. Increases of WBC count, abnormalities in morphological features of white blood cells, including a low percentage of blast cells, high percentage of monocytes, presence of atypical monocytes and certain dysplastic features in neuphile cells, are critical characteristics for the early and accurate diagnosis of MDS/MPN.
